| Name |
Recombinant Human LILRA2/CD85h/ILT1 Protein, CF
|
| Supplier |
R&D Systems
|
| Catalog |
9040-T4
|
| Category |
Protein
|
| Prices |
$339.00
|
| Sizes |
50 µg
|
| Species Reactivities |
Human
|
| Nature |
Recombinant
|
| Source |
Human embryonic kidney cell, HEK293-derived Gly24-Asn449, with a C-terminal 6-His tag
|
| Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Measured by its binding ability in a functional ELISA. When Recombinant Human LILRA2/CD85h/ILT1 is coated at 2 µg/mL, Recombinant Human Angiopoietin-like Protein 7/ANGPTL7. (Catalog # 914-AN ) binds with a typical ED 50 of 150-900 ng/mL.
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| SwissProt/Accession |
NP_001124389
|
| Gene |
LILRA2
|
| Sequence |
Gly24
|
| Supplier Page |
Shop
|
When Recombinant Human LILRA2/CD85h/ILT1 (Catalog # 9040-T4) is coated at 2 µg/mL, Recombinant Human Angiopoietin-like 7 Protein (Catalog # 914-AN) binds with a typical ED 50 of150-900 ng/mL.